A bill to require the Secretary of Health and Human Services to prepare a report that outlines a plan for completing a review of approved opioid analgesic drugs that considers the public health effects of such opioid drugs.

Bill 118 s 3557, also known as the "Opioid Analgesic Drug Review Act," is a proposed piece of legislation that aims to address the ongoing opioid crisis in the United States. The bill would require the Secretary of Health and Human Services to prepare a report that outlines a plan for completing a review of approved opioid analgesic drugs. This review would specifically consider the public health effects of these drugs.

The goal of the bill is to ensure that opioid analgesic drugs are being used in a safe and responsible manner, taking into account the potential risks and benefits associated with their use. By conducting a thorough review of these drugs, the Secretary of Health and Human Services would be able to provide valuable information to policymakers, healthcare providers, and the general public about the impact of opioid analgesics on public health.

Overall, Bill 118 s 3557 represents a proactive approach to addressing the opioid crisis by promoting greater transparency and accountability in the approval and use of opioid analgesic drugs. It is an important step towards ensuring that these powerful medications are being used in a way that prioritizes public health and safety.